Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
AL002 Alzheimer's Disease (Phase 1) AbbVie, Alector Inflammation Immunotherapy (passive)
AL003 Alzheimer's Disease (Phase 1) AbbVie, Alector Inflammation Immunotherapy (active)
AZP2006 AZP-2006 Progressive Supranuclear Palsy (Phase 2), Alzheimer's Disease (Phase 1) AlzProtect Tau, Inflammation, Other Small Molecule
GC 021109 Alzheimer's Disease (Phase 1) GliaCure Inflammation Small Molecule
GENUS Gamma entrainment using sensory stimuli Alzheimer's Disease (Phase 1) Cognito Therapeutics, Inc. Amyloid-Related, Inflammation, Other Combination, Procedural Intervention
Inzomelid Alzheimer's Disease (Phase 1), Parkinson's Disease (Phase 1) Inflazome Ltd. Inflammation Small Molecule
JNJ-40346527 Edicotinib,
JNJ-527,
PRV-6527
Alzheimer's Disease (Phase 1) Janssen Inflammation Small Molecule
MW151 MW01-2-151SRM,
Minozac,
MW01-2-151WH,
compound 17
Alzheimer's Disease (Phase 1) ImmunoChem Therapeutics, LLC Inflammation Small Molecule
XPro1595 INB03, NeuLiv, XENP1595, DN-TNF, XENP345 Alzheimer's Disease (Phase 1) INmune Bio Inc. Inflammation Other